id	sid	eid	entity	type
dti-1426	1	1	1drug	CARDINAL
dti-1426	1	2	2016:10(s1	CARDINAL
dti-1426	1	3	federico de marco3	PERSON
dti-1426	1	4	fraser w.h. sutherland1	PERSON
dti-1426	1	5	massimo chello5	PERSON
dti-1426	1	6	marcella trombetta6	PERSON
dti-1426	1	7	clydebank	ORG
dti-1426	1	8	uk	GPE
dti-1426	1	9	2cardiac	CARDINAL
dti-1426	1	10	du nord de saint-denis	ORG
dti-1426	1	11	paris	GPE
dti-1426	1	12	france	GPE
dti-1426	2	1	3laboratory	CARDINAL
dti-1426	2	2	the regina elena national cancer institute	ORG
dti-1426	2	3	rome	GPE
dti-1426	2	4	italy	GPE
dti-1426	3	1	4unit	CARDINAL
dti-1426	3	2	università campus bio-medico di roma	PERSON
dti-1426	3	3	rome	GPE
dti-1426	3	4	italy	GPE
dti-1426	4	1	5unit	CARDINAL
dti-1426	4	2	università campus bio-medico di roma	PERSON
dti-1426	4	3	rome	GPE
dti-1426	4	4	italy	GPE
dti-1426	5	1	6tissue	CARDINAL
dti-1426	5	2	università campus bio-medico di roma	PERSON
dti-1426	5	3	rome	GPE
dti-1426	5	4	italy	GPE
dti-1426	10	1	four weeks	DATE
dti-1426	13	1	2016:10(s1	CARDINAL
dti-1426	13	2	1–7 doi:10.4137/dti.s35202	MONEY
dti-1426	14	1	september 25, 2015	DATE
dti-1426	15	1	november 12, 2015	DATE
dti-1426	16	1	november 16, 2015	DATE
dti-1426	17	1	anuj chauhan	PERSON
dti-1426	17	2	three	CARDINAL
dti-1426	18	1	507	CARDINAL
dti-1426	22	1	3.0	CARDINAL
dti-1426	27	1	third	ORDINAL
dti-1426	34	1	allografts	PERSON
dti-1426	34	2	xenografts	GPE
dti-1426	35	1	tevg	PERSON
dti-1426	36	1	6	CARDINAL
dti-1426	36	2	4	CARDINAL
dti-1426	39	1	approximately eight	CARDINAL
dti-1426	40	1	2015	CARDINAL
dti-1426	40	2	9(s1	CARDINAL
dti-1426	41	1	http://www.la-press.com/drug-target-insights-journal-j23	CARDINAL
dti-1426	41	2	al 2	ORG
dti-1426	41	3	2016:10(s1	CARDINAL
dti-1426	41	4	75 per cent	MONEY
dti-1426	41	5	48 weeks	DATE
dti-1426	42	1	ecm	ORG
dti-1426	42	2	scale.10	PERSON
dti-1426	43	1	ecm fibrillar	PERSON
dti-1426	44	1	pcl	ORG
dti-1426	44	2	three	CARDINAL
dti-1426	44	3	3d	CARDINAL
dti-1426	45	1	pcl	ORG
dti-1426	46	1	ecm	ORG
dti-1426	47	1	pcl	ORG
dti-1426	50	1	13%	PERCENT
dti-1426	50	2	5000	CARDINAL
dti-1426	51	1	830 mg	QUANTITY
dti-1426	51	2	5 mm	QUANTITY
dti-1426	51	3	6 cm	QUANTITY
dti-1426	51	4	methods.13,20	GPE
dti-1426	51	5	pcl	ORG
dti-1426	51	6	80	CARDINAL
dti-1426	53	1	10	CARDINAL
dti-1426	53	2	new zealand	GPE
dti-1426	53	3	1.8–2.1  kg	QUANTITY
dti-1426	53	4	charles river laboratory	ORG
dti-1426	53	5	three weeks	DATE
dti-1426	54	1	pcl	ORG
dti-1426	57	1	3drug	ORG
dti-1426	57	2	2016:10(s1	CARDINAL
dti-1426	58	1	the regina elena institute	ORG
dti-1426	59	1	i.m.	GPE
dti-1426	60	1	25	CARDINAL
dti-1426	61	1	37°	QUANTITY
dti-1426	62	1	23	CARDINAL
dti-1426	65	1	100	CARDINAL
dti-1426	65	2	8–0	CARDINAL
dti-1426	66	1	aorta	PERSON
dti-1426	66	2	8–0	CARDINAL
dti-1426	67	1	two	CARDINAL
dti-1426	68	1	1	CARDINAL
dti-1426	69	1	3–0	CARDINAL
dti-1426	69	2	ethicon	ORG
dti-1426	71	1	30 minutes	TIME
dti-1426	72	1	0.5 mg/kg	QUANTITY
dti-1426	73	1	the first three days	DATE
dti-1426	73	2	0.5 mg/kg	QUANTITY
dti-1426	74	1	100  mg/kg	QUANTITY
dti-1426	76	1	daily	DATE
dti-1426	77	1	four weeks	DATE
dti-1426	80	1	2 mg/kg	QUANTITY
dti-1426	81	1	3d	CARDINAL
dti-1426	81	2	mip	ORG
dti-1426	83	1	4%	PERCENT
dti-1426	84	1	6 mm	QUANTITY
dti-1426	84	2	hematoxylin	PERSON
dti-1426	88	1	four weeks	DATE
dti-1426	89	1	2	CARDINAL
dti-1426	92	1	ecm	ORG
dti-1426	93	1	1	CARDINAL
dti-1426	95	1	two	CARDINAL
dti-1426	96	1	http://www.la-press.com/drug-target-insights-journal-j23	CARDINAL
dti-1426	96	2	al 4	FAC
dti-1426	96	3	2016:10(s1	CARDINAL
dti-1426	98	1	3	CARDINAL
dti-1426	100	1	2	CARDINAL
dti-1426	103	1	3d	CARDINAL
dti-1426	103	2	mip	ORG
dti-1426	104	1	3	CARDINAL
dti-1426	106	1	hematoxylin	PERSON
dti-1426	108	1	5×	CARDINAL
dti-1426	109	1	10×	CARDINAL
dti-1426	110	1	40×	CARDINAL
dti-1426	112	1	40×	CARDINAL
dti-1426	116	1	5drug	CARDINAL
dti-1426	116	2	2016:10(s1	CARDINAL
dti-1426	116	3	two	CARDINAL
dti-1426	117	1	application.26–28	PERSON
dti-1426	117	2	pcl	ORG
dti-1426	118	1	first	ORDINAL
dti-1426	118	2	second	ORDINAL
dti-1426	119	1	third	ORDINAL
dti-1426	119	2	90°	QUANTITY
dti-1426	126	1	differentiation.33,34	FAC
dti-1426	127	1	four weeks	DATE
dti-1426	130	1	first	ORDINAL
dti-1426	132	1	second	ORDINAL
dti-1426	138	1	3d	CARDINAL
dti-1426	138	2	ecm	ORG
dti-1426	143	1	http://www.la-press.com/drug-target-insights-journal-j23	CARDINAL
dti-1426	143	2	6	CARDINAL
dti-1426	143	3	2016:10(s1	CARDINAL
dti-1426	147	1	second	ORDINAL
dti-1426	148	1	third	ORDINAL
dti-1426	151	1	first	ORDINAL
dti-1426	152	1	second	ORDINAL
dti-1426	153	1	third	ORDINAL
dti-1426	157	1	first	ORDINAL
dti-1426	157	2	mc,	GPE
dti-1426	157	3	mt	GPE
dti-1426	157	4	mc,	ORG
dti-1426	157	5	mt	GPE
dti-1426	158	1	mc,	ORG
dti-1426	160	1	1	CARDINAL
dti-1426	161	1	zhang wj	PERSON
dti-1426	161	2	li	PERSON
dti-1426	163	1	2008;29(10	CARDINAL
dti-1426	163	2	1464–1472	CARDINAL
dti-1426	164	1	2	CARDINAL
dti-1426	164	2	yang f	PERSON
dti-1426	164	3	murugan	PERSON
dti-1426	164	4	wang s	PERSON
dti-1426	167	1	2005;26(15):2603–2610	CARDINAL
dti-1426	168	1	3	CARDINAL
dti-1426	168	2	shinoka t	GPE
dti-1426	168	3	shum-tim	PERSON
dti-1426	168	4	ma px	PERSON
dti-1426	171	1	1998;115(3	CARDINAL
dti-1426	172	1	536–545	DATE
dti-1426	173	1	545–536	CARDINAL
dti-1426	174	1	4	CARDINAL
dti-1426	174	2	shin’oka t	PERSON
dti-1426	174	3	matsumura g	PERSON
dti-1426	174	4	hibino n	GPE
dti-1426	177	1	2005;129(6):1330–1338	CARDINAL
dti-1426	177	2	5	CARDINAL
dti-1426	177	3	w	GPE
dti-1426	177	4	ma z	PERSON
dti-1426	177	5	teo	PERSON
dti-1426	179	1	j biomed mater res	PERSON
dti-1426	179	2	a. 2009;90(1):205–216	PERSON
dti-1426	180	1	6	CARDINAL
dti-1426	181	1	carr	PERSON
dti-1426	181	2	sharma h	ORG
dti-1426	184	1	1996;10(5):469–475	CARDINAL
dti-1426	185	1	7	CARDINAL
dti-1426	185	2	rosenman je	PERSON
dti-1426	185	3	kempczinski	PERSON
dti-1426	185	4	pearce wh	PERSON
dti-1426	187	1	1985;2(6):778–784	CARDINAL
dti-1426	187	2	8	CARDINAL
dti-1426	187	3	kim du	PERSON
dti-1426	187	4	1	CARDINAL
dti-1426	189	1	1992;112(2):244–254	CARDINAL
dti-1426	191	1	9	CARDINAL
dti-1426	191	2	spadaccio c	ORG
dti-1426	193	1	2009;13(3):422–439	CARDINAL
dti-1426	194	1	10	CARDINAL
dti-1426	194	2	mo xm	PERSON
dti-1426	194	3	xu cy	PERSON
dti-1426	194	4	kotaki m	PERSON
dti-1426	195	1	p(lla-cl	PERSON
dti-1426	197	1	11	CARDINAL
dti-1426	197	2	kreke	PERSON
dti-1426	197	3	thompson ms	PERSON
dti-1426	198	1	2006;27(4):596–606	CARDINAL
dti-1426	199	1	12	CARDINAL
dti-1426	202	1	eng	GPE
dti-1426	203	1	13	CARDINAL
dti-1426	203	2	spadaccio c	ORG
dti-1426	205	1	2010;5(4):645–657	CARDINAL
dti-1426	206	1	14	CARDINAL
dti-1426	207	1	zhu y	PERSON
dti-1426	207	2	yang gy	PERSON
dti-1426	208	1	sci u s a. 2007;104(29):11915–11920	PERSON
dti-1426	208	2	15	CARDINAL
dti-1426	209	1	barnes cp	PERSON
dti-1426	209	2	boland ed	ORG
dti-1426	210	1	adv drug deliv	ORG
dti-1426	211	1	2007;59(14	CARDINAL
dti-1426	211	2	1413–1433	CARDINAL
dti-1426	212	1	16	CARDINAL
dti-1426	213	1	ramakrishna s. nano-	PERSON
dti-1426	214	1	eng	GPE
dti-1426	214	2	2006;12(3):435–447	CARDINAL
dti-1426	214	3	17	CARDINAL
dti-1426	215	1	lee sj	PERSON
dti-1426	215	2	yoo jj, lim gj	PERSON
dti-1426	217	1	j biomed mater res	PERSON
dti-1426	217	2	a. 2007;83(4):999–1008	PERSON
dti-1426	218	1	18	CARDINAL
dti-1426	219	1	mironov	PERSON
dti-1426	219	2	kasyanov	PERSON
dti-1426	221	1	biotechnol	GPE
dti-1426	222	1	2008;26(6):338–344	CARDINAL
dti-1426	222	2	19	CARDINAL
dti-1426	223	1	kim	PERSON
dti-1426	223	2	nederberg f	GPE
dti-1426	223	3	zhang l	PERSON
dti-1426	223	4	nanostructured organosilicate	ORG
dti-1426	225	1	2008;8(1):294–301	CARDINAL
dti-1426	225	2	20	CARDINAL
dti-1426	226	1	centola m	PERSON
dti-1426	229	1	21	CARDINAL
dti-1426	230	1	giannitelli sm	PERSON
dti-1426	232	1	acta biomater	PERSON
dti-1426	234	1	580–594	CARDINAL
dti-1426	235	1	22	CARDINAL
dti-1426	236	1	giannitelli sm	PERSON
dti-1426	238	1	acta biomater	PERSON
dti-1426	239	1	2015;24:1–11	CARDINAL
dti-1426	240	1	23	CARDINAL
dti-1426	241	1	lobo bl	PERSON
dti-1426	241	2	greene wl	PERSON
dti-1426	242	1	accp	PERSON
dti-1426	246	1	24	CARDINAL
dti-1426	247	1	tillman bw	PERSON
dti-1426	247	2	yazdani sk	PERSON
dti-1426	247	3	lee sj	PERSON
dti-1426	249	1	2009;30(4):583–588	CARDINAL
dti-1426	250	1	25	CARDINAL
dti-1426	250	2	de mulder pa	PERSON
dti-1426	250	3	van kerckhoven rj	PERSON
dti-1426	250	4	adriaensen hf	PERSON
dti-1426	252	1	sci	ORG
dti-1426	253	1	1997;47(4):367–375	ORDINAL
dti-1426	254	1	7drug	ORG
dti-1426	254	2	2016:10(s1	CARDINAL
dti-1426	254	3	26	CARDINAL
dti-1426	255	1	isenberg bc	PERSON
dti-1426	255	2	williams c	PERSON
dti-1426	255	3	tranquillo rt	PERSON
dti-1426	256	1	circ res	ORG
dti-1426	257	1	2006;98(1):25–35	CARDINAL
dti-1426	257	2	27	CARDINAL
dti-1426	259	1	nat clin pract cardiovasc med	ORG
dti-1426	260	1	2007;4(7):389–395	CARDINAL
dti-1426	260	2	28	CARDINAL
dti-1426	260	3	stegemann jp	PERSON
dti-1426	260	4	kaszuba sn	PERSON
dti-1426	260	5	rowe sl.	ORG
dti-1426	261	1	eng	GPE
dti-1426	262	1	2007;13(11	CARDINAL
dti-1426	262	2	2601–2613	DATE
dti-1426	263	1	29	CARDINAL
dti-1426	267	1	2002;24(6	CARDINAL
dti-1426	267	2	540–544	DATE
dti-1426	267	3	30	CARDINAL
dti-1426	268	1	wisselink w	PERSON
dti-1426	268	2	sr	ORG
dti-1426	268	3	crockett de	PERSON
dti-1426	270	1	1994;20(3):444–491	CARDINAL
dti-1426	271	1	449–450	CARDINAL
dti-1426	272	1	31	CARDINAL
dti-1426	273	1	chandy t	PERSON
dti-1426	273	2	rao gh	PERSON
dti-1426	273	3	wilson	PERSON
dti-1426	275	1	2002;9(2):87–96	CARDINAL
dti-1426	276	1	32	CARDINAL
dti-1426	277	1	philbrick jt	PERSON
dti-1426	278	1	acp j club	PRODUCT
dti-1426	279	1	2002;136(1):9	CARDINAL
dti-1426	280	1	33	CARDINAL
dti-1426	282	1	fischer	PERSON
dti-1426	285	1	2003;64(3):696–702	CARDINAL
dti-1426	285	2	34	CARDINAL
dti-1426	285	3	serizawa n	ORG
dti-1426	285	4	takei y	PERSON
dti-1426	287	1	2006;34(4):207–213	CARDINAL
dti-1426	287	2	35	CARDINAL
dti-1426	288	1	de porcellinis s	ORG
dti-1426	291	1	2010;2010:843–846	CARDINAL
dti-1426	292	1	36	CARDINAL
dti-1426	292	2	spadaccio c	ORG
dti-1426	295	1	2011;15(5):1096–1108	CARDINAL
dti-1426	296	1	37	DATE
dti-1426	296	2	spadaccio c	ORG
dti-1426	297	1	ann biomed eng	PERSON
dti-1426	297	2	2009;37(7):1376–1389	CARDINAL
dti-1426	298	1	38	CARDINAL
dti-1426	299	1	rainer	PERSON
dti-1426	299	2	electrospun	NORP
dti-1426	300	1	ann biomed eng	PERSON
dti-1426	300	2	2011;39(7):1882–1890	DATE